fdafinancialdisclosurerules.blogspot.com
FDA Financial Disclosure Rules: November 2005
http://fdafinancialdisclosurerules.blogspot.com/2005_11_01_archive.html
FDA Financial Disclosure Rules. Tuesday, November 22, 2005. Financial Disclosure Required by Clinical Investigators. As written by Shilpa Sadekar. Drug companies submitting licensing applications to the Food and Drug Administration (FDA) in the United States will now have to reveal whether researchers involved in a drug trial have any financial interest in the company. The new regulations aim to eliminate possible data bias arising from financial considerations [3]. Under the applicable regulations (21 C...
fdafinancialdisclosurerules.blogspot.com
FDA Financial Disclosure Rules: Financial Disclosure Required by Clinical Investigators
http://fdafinancialdisclosurerules.blogspot.com/2005/11/financial-disclosure-required-by.html
FDA Financial Disclosure Rules. Tuesday, November 22, 2005. Financial Disclosure Required by Clinical Investigators. As written by Shilpa Sadekar. Drug companies submitting licensing applications to the Food and Drug Administration (FDA) in the United States will now have to reveal whether researchers involved in a drug trial have any financial interest in the company. The new regulations aim to eliminate possible data bias arising from financial considerations [3]. Under the applicable regulations (21 C...
incentivesclinicaltrials.blogspot.com
Incentives for Clinical Trial Participants: Offering Incentives to Participants in Clinical Trials
http://incentivesclinicaltrials.blogspot.com/2005/11/offering-incentives-to-participants-in.html
Incentives for Clinical Trial Participants. Monday, November 14, 2005. Offering Incentives to Participants in Clinical Trials. This information has been published by the International Biopharmaceutical Association http:/ www.ibpassociation.org/. Please note this information does not give any medical advice. The project is sponsored by Kriger Research Center - CRO and Training Services ( http:/ www.kriger.com/. ClinQua CRO ( http:/ www.clinqua.com/. And Altaspera Designs ( http:/ www.altaspera.com/. Payme...
reducingclinicalfraud.blogspot.com
Reducing Clinical Fraud: How to Reduce Clinical Fraud
http://reducingclinicalfraud.blogspot.com/2005/11/how-to-reduce-clinical-fraud.html
View my complete profile. Monday, November 28, 2005. How to Reduce Clinical Fraud. Patrick T. Busby. There are many different ways that fraud can occur throughout a single clinical trial. There are also many examples provided to show that fraud is an issue when it comes to clinical trials today. It is not hard to reduce this fraud as it only takes one person to notice that it is occurring and a stop to the trial can come immediately after. Please note this information does not give any medical advice.
harvardmouse.blogspot.com
Harvard Mouse: The Laboratory Oncomouse
http://harvardmouse.blogspot.com/2006/03/laboratory-oncomouse.html
Friday, March 17, 2006. From Wikipedia, the free encyclopedia. The Oncomouse or Harvard mouse is a type of laboratory mouse. That has been genetically modified. To carry a specific gene. Called an activated oncogene. The activated oncogene significantly increases the mouse’s susceptibility to cancer. And thus makes the mouse suitable for cancer research. Applications on the oncomouse were filed back in the mid- 1980s. In numerous countries such as in the United States. Through the European Patent Office.
harvardmouse.blogspot.com
Harvard Mouse: March 2006
http://harvardmouse.blogspot.com/2006_03_01_archive.html
Friday, March 17, 2006. From Wikipedia, the free encyclopedia. The Oncomouse or Harvard mouse is a type of laboratory mouse. That has been genetically modified. To carry a specific gene. Called an activated oncogene. The activated oncogene significantly increases the mouse’s susceptibility to cancer. And thus makes the mouse suitable for cancer research. Applications on the oncomouse were filed back in the mid- 1980s. In numerous countries such as in the United States. Through the European Patent Office.
